Trial intelligence / Profile preview

Tropisetron to prevent transition from acute to chronic pain after cesarean section

ChiCTR1900022044Phase 4Recruiting

Sponsor
Shiyan Taihe Hospital
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tropisetron in postoperative pain, Persistent postsurgical pain (PPSP) and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shiyan Taihe Hospital. Primary endpoints: Pain Numerical Rating Scale, Self-Rating Anxiety Scale and 1 more. Started Jan 2019; status: recruiting.

02

Drugs

tropisetron
03

Conditions

postoperative painPersistent postsurgical pain (PPSP)postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR1900022044.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022044.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call